"Let's continue, let's continue studying Sisi's illness." Yang Ping pointed to the image on the electronic screen.
After several treatments, Sisi's condition has significantly improved. Compared to previous exams, all the tumors in her body are shrinking, and some scattered tumor images have disappeared.
It is evident that the K Virus is very effective in treating this type of tumor in Sisi. However, K biotherapeutics (K Virus) are obtained through gene recombination, and they are currently not very stable. After a certain number of iterations, they undergo mutations that make the K Virus eventually mediocre, losing its lethality against tumors.
"The feedback from the laboratory is that all the seed K biotherapeutics have failed, as they all underwent mutations during iteration, losing their therapeutic capability."
Song Zimo said regretfully.
Yang Ping thought for a moment: "Recreate the K biotherapeutics using gene recombination technology. Spare no expense."
